Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Receives Notice of Allowance from USPTO on Expressed RNAi Application


Benitec said this week that the US Patent and Trademark Office has issued the company a notice of allowance on a patent application covering its core expressed RNAi technology.

The application, No. 20040266005, is entitled “Synthetic Genes and Genetic Constructs,” and claims “novel synthetic genes and genetic constructs which are capable of repressing, delaying, or otherwise reducing the expression of an endogenous gene or a target gene in an organism,” according to its abstract.

According to Benitec, the claims in the application are “complementary” to those contained within its core US patent No. 6,573,099.

That patent claims the knockdown of gene expression using DNA that transcribes double-stranded RNA, and was one of the first US patents in the RNAi field. As part of a protracted legal battle with now-defunct expressed RNAi drug shop Nucleonics, the '099 patent was invalided by the USPTO.

However, the agency reversed its ruling late last year (GSN 11/11/2010).

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.